Allan Wailoo

6.7k total citations · 1 hit paper
123 papers, 4.6k citations indexed

About

Allan Wailoo is a scholar working on Economics and Econometrics, General Health Professions and Rheumatology. According to data from OpenAlex, Allan Wailoo has authored 123 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Economics and Econometrics, 33 papers in General Health Professions and 32 papers in Rheumatology. Recurrent topics in Allan Wailoo's work include Health Systems, Economic Evaluations, Quality of Life (70 papers), Healthcare Policy and Management (24 papers) and Rheumatoid Arthritis Research and Therapies (22 papers). Allan Wailoo is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (70 papers), Healthcare Policy and Management (24 papers) and Rheumatoid Arthritis Research and Therapies (22 papers). Allan Wailoo collaborates with scholars based in United Kingdom, United States and Netherlands. Allan Wailoo's co-authors include Mónica Hernández Alava, Keith R. Abrams, Alex J. Sutton, Roberta Ara, Aki Tsuchiya, Paul C. Lambert, David Turner, Nicola J. Cooper, Stephen Pudney and Mike Bradburn and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Allan Wailoo

117 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study

2016 296 citations Mike Bradburn, Allan Wailoo et al. Health Technology Assessment profile →

Peers

Countries citing papers authored by Allan Wailoo

Since Specialization

Citations

This map shows the geographic impact of Allan Wailoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan Wailoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan Wailoo more than expected).

Fields of papers citing papers by Allan Wailoo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan Wailoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan Wailoo. The network helps show where Allan Wailoo may publish in the future.

Co-authorship network of co-authors of Allan Wailoo

This figure shows the co-authorship network connecting the top 25 collaborators of Allan Wailoo. A scholar is included among the top collaborators of Allan Wailoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan Wailoo. Allan Wailoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Does EQ-5D Tell the Whole Story? Statistical Methods for Comparing the Thematic Coverage of Clinical and Generic Outcome Measures, With Application to Breast Cancer 2023 ·Value in Health ·Mónica Hernández Alava, Stephen Pudney, Allan Wailoo	2
2	Measuring quality of life of patients with axial spondyloarthritis for economic evaluation 2022 ·RMD Open ·Mónica Hernández Alava, Allan Wailoo, (unknown), (unknown), F. van Gaalen, Helena Santos, K. M. Fagerli, (unknown), Maria Margarida Cunha, Marleen van de Sande, Maura Couto, Miguel Bernardes, Roberta Ramonda, Sofia Exarchou, (unknown), Désirée van der Heijde, Pedro Machado	3
3	Protocol for the ORION trial (RadiO fRequency ablatION for haemorrhoids): a randomised controlled trial 2022 ·Techniques in Coloproctology ·(unknown), Matthew J. Lee, (unknown), (unknown), (unknown), Allan Wailoo, Mike Bradburn, Daniel Hind, (unknown), (unknown), Steven R. Brown	1
4	Treat-to-Target Strategies in Rheumatoid Arthritis: a Systematic Review and Cost-Effectiveness Analysis 2021 ·SN Comprehensive Clinical Medicine ·Emma Everson-Hock, Marrissa Martyn‐St James, Allan Wailoo, David L. Scott, Matt Stevenson, Andrew Rawdin, Emma Simpson, (unknown), Adam Young	7
5	Intensive therapy for moderate established rheumatoid arthritis: the TITRATE research programme 2021 ·SHILAP Revista de lepidopterología ·David L. Scott, Fowzia Ibrahim, Harry Hill, Brian D. M. Tom, (unknown), (unknown), Ailsa Bosworth, James Galloway, Sofia Georgopoulou, Naomi Martin, (unknown), Elena Nikiphorou, Jackie Sturt, Allan Wailoo, Frances M. K. Williams, Ruth Williams, Heidi Lempp	1
6	An International Comparison of EQ-5D-5L and EQ-5D-3L for Use in Cost-Effectiveness Analysis 2021 ·Value in Health ·Allan Wailoo, Mónica Hernández Alava, Stephen Pudney, Garry Barton, John O’Dwyer, Manuel Gomes, Lisa Irvine, David Meads, Zia Sadique	18
7	A Review of the Psychometric Performance of Selected Child and Adolescent Preference-Based Measures Used to Produce Utilities for Child and Adolescent Health 2020 ·Value in Health ·Donna Rowen, Anju Keetharuth, Edith Poku, Ruth Wong, Becky Pennington, Allan Wailoo	39
8	MRI in the diagnosis of fetal developmental brain abnormalities: the MERIDIAN diagnostic accuracy study 2019 ·Health Technology Assessment ·Paul D. Griffiths, Mike Bradburn, Michael J. Campbell, Cindy Cooper, Nicholas D. Embleton, Ruth Graham, Anthony R Hart, Deborah Jarvis, Mark D. Kilby, Mabel Lie, Gerald Mason, Laura Mandefield, Cara Mooney, Becky Pennington, Stephen C. Robson, Allan Wailoo	38
9	The Impact of Moving from EQ-5D-3L to -5L in NICE Technology Appraisals 2018 ·PharmacoEconomics ·Becky Pennington, Mónica Hernández Alava, Stephen Pudney, Allan Wailoo	21
10	The feasibility of early pulmonary rehabilitation and activity after COPD exacerbations: external pilot randomised controlled trial, qualitative case study and exploratory economic evaluation 2018 ·Health Technology Assessment ·(unknown), Catherine O’Connor, Katie Biggs, Daniel Hind, Oscar Bortolami, Matthew Franklin, Barbara Collins, Stephen J. Walters, Allan Wailoo, (unknown), Paul Albert, (unknown), Stephen C Bourke, Michael Steiner, (unknown), (unknown), David McWilliams, (unknown), John O’Reilly, Rodney Hughes	21
11	Mapping the FACT-B Instrument to EQ-5D-3L in Patients with Breast Cancer Using Adjusted Limited Dependent Variable Mixture Models versus Response Mapping 2018 ·Value in Health ·Laura A. Gray, Allan Wailoo, Mónica Hernández Alava	25
12	Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report 2017 ·Value in Health ·Allan Wailoo, Mónica Hernández Alava, Andrea Manca, (unknown), Joshua Ray, Bruce Crawford, Marc Botteman, Jan J.V. Busschbach	150
13	Abstract 15628: The Use of Antibiotic Prophylaxis to Prevent Infective Endocarditis is Cost Effective 2016 ·Circulation ·Matthew Franklin, Allan Wailoo, Mark Dayer, Simon Jones, Bernard Prendergast, Larry M. Baddour, Peter B. Lockhart, Martin H. Thornhill	1
14	Valuing health at the end of life: A stated preference discrete choice experiment 2014 ·Social Science & Medicine ·Koonal Shah, Aki Tsuchiya, Allan Wailoo	64
15	A Guide to Adjusting Survival Time Estimates to Account for Treatment Switching in Randomised Controlled Trials 2013 ·Value in Health ·Nicholas Latimer, Keith R. Abrams, Paul C. Lambert, Michael J. Crowther, Allan Wailoo, James P. Morden, Ron Akehurst, Michael J. Campbell	22
16	Tails from the Peak District: Adjusted Limited Dependent Variable Mixture Models of EQ-5D Questionnaire Health State Utility Values 2012 ·Value in Health ·Mónica Hernández Alava, Allan Wailoo, Roberta Ara	138
17	The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review 2006 ·Health Technology Assessment ·Martin Connock, Amanda Burls, Emma Frew, A Fry-Smith, A. Juarez-Garcia, Christopher J. McCabe, Allan Wailoo, Keith R. Abrams, N.J. Cooper, Alex J. Sutton, Anthony O’Hagan, David Moore	69
18	The nature and impact of urinary incontinence experienced by patients receiving community nursing services: A cross-sectional cohort study 2006 ·International Journal of Nursing Studies ·Francine Cheater, Richard Baker, Clare Gillies, Allan Wailoo, Nicola Spiers, (unknown), Noelle Robertson, (unknown)	17
19	Procedural Justice in Public Healthcare Resource Allocation 2005 ·Applied Health Economics and Health Policy ·Aki Tsuchiya, L. Silva Miguel, Richard Edlin, Allan Wailoo, Paul Dolan	17
20	Systematic review and economic decision modelling for the prevention and treatment of influenza A and B 2003 ·Health Technology Assessment ·David Turner, Allan Wailoo, Karl G. Nicholson, Nicola J. Cooper, Alex J. Sutton, Keith R. Abrams	188

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact